PHARMACOKINETICS OF DOXORUBICIN AND ITS METABOLITE DOXORUBICINOL IN RABBITS WITH INDUCED ACID AND ALKALINE URINE

被引：14
作者：
JOHANSEN, PB
JENSEN, SE
RASMUSSEN, SN
DALMARK, M
机构：
[1] ROYAL DANISH SCH PHARM,DEPT BIOL,DK-2100 COPENHAGEN O,DENMARK
[2] FINSEN INST,DEPT A,RADIUM STN,DK-2100 COPENHAGEN O,DENMARK
来源：
CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1984年 / 13卷 / 01期
关键词：
D O I：
10.1007/BF00401437
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：5 / 8
页数：4
相关论文
共 50 条
[31]   Pharmacokinetics of diltiazem and its major metabolite, deacetyldiltiazem after oral administration of diltiazem in mild and medium folate-induced renal failure rabbits [J].
Choi, JS ;
Lee, JH ;
Burm, JP .
ARCHIVES OF PHARMACAL RESEARCH, 2001, 24 (04) :333-337
[32]   Pharmacokinetics of verapamil and its metabolite norverapamil in rats with hyperlipidaemia induced by poloxamer 407 [J].
Lee, Young Sun ;
Yoon, Ji Na ;
Yoon, In-Soo ;
Lee, Myung Gull ;
Kang, Hee Eun .
XENOBIOTICA, 2012, 42 (08) :766-774
[33]   Pharmacokinetics of active component of Chrysanthemum morifolium extracts and its acid hydrolysate in rabbits [J].
Li, Li-Ping ;
Jiang, Hui-Di ;
Wu, Hao-Hao ;
Ting, Chen .
Chinese Pharmaceutical Journal, 2005, 40 (24) :1884-1887
[34]   PHARMACOKINETICS OF LIDOCAINE AND ITS MAJOR METABOLITE - MONOETHYLGLYCINEXYLIDIDE (MEGX) IN RABBITS WITH EXPERIMENTAL COMMON BILE-DUCT OBSTRUCTION [J].
WOJCICKI, J ;
SULIKOWSKI, T ;
WOJCICKI, M ;
DROZDZIK, M ;
GAWRONSKASZKLARZ, B ;
BARCEWWISZNIEWSKA, B ;
SKOWRON, J ;
ROZEWICKA, L ;
GOLDYN, U .
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1995, 20 (02) :119-123
[35]   Pharmacokinetics of remifentanil and its major metabolite, remifentanil acid, in ICU patients with renal impairment [J].
Pitsiu, M ;
Wilmer, A ;
Bodenham, A ;
Breen, D ;
Bach, V ;
Bonde, J ;
Kessler, P ;
Albrecht, S ;
Fisher, G ;
Kirkham, A .
BRITISH JOURNAL OF ANAESTHESIA, 2004, 92 (04) :493-503
[36]   Effect of cyclosporine A and tacrolimus on pharmacokinetics of mycophenolic acid and its metabolite in kidney transplant recipients [J].
Merkel, U ;
Lauerwald, W ;
Sperschneider, H ;
Vollandt, R ;
Balogh, A .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 58 (07) :S96-S96
[37]   Mechanistic Study on the Effect of Renal Impairment on the Pharmacokinetics of Vildagliptin and its Carboxylic Acid Metabolite [J].
Guo, Zitao ;
Kong, Fandi ;
Xie, Ningjie ;
Chen, Zhendong ;
Hu, Jiafeng ;
Chen, Xiaoyan .
PHARMACEUTICAL RESEARCH, 2022, 39 (09) :2147-2162
[38]   Folic acid and its metabolite codetermination for pharmacokinetics with circadian rhythms and evaluation of oral bioavailability [J].
Meng, Fanyue ;
Zhang, Guoqing ;
Wang, Caifen ;
Zhu, Rui ;
Li, Haiyan ;
Xu, Jian ;
Shakya, Shailendra ;
Chen, Weidong ;
Wu, Li ;
Zhang, Jiwen .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2019, 71 (11) :1645-1654
[39]   Mechanistic Study on the Effect of Renal Impairment on the Pharmacokinetics of Vildagliptin and its Carboxylic Acid Metabolite [J].
Zitao Guo ;
Fandi Kong ;
Ningjie Xie ;
Zhendong Chen ;
Jiafeng Hu ;
Xiaoyan Chen .
Pharmaceutical Research, 2022, 39 :2147-2162
[40]   Relative Quantification of the Metabolite of Aconitine in Rat Urine by LC-ESI-MS/MS and Its Application to Pharmacokinetics [J].
He, Huiwen ;
Yan, Fei .
ANALYTICAL SCIENCES, 2012, 28 (12) :1203-1205
12345